Patents by Inventor Mark Nitz

Mark Nitz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7722890
    Abstract: The present invention provides methods of making and using immunogenic oligosaccharide compositions comprising native O-linked and S-linked oligosaccharides coupled to a protein carrier, wherein the resultant conjugate elicits a protectively immunogenic response. These compositions may be useful in vaccines against pathogenic Candida species.
    Type: Grant
    Filed: April 25, 2003
    Date of Patent: May 25, 2010
    Assignee: Theracarb, Inc.
    Inventors: David R. Bundle, Mark Nitz, Jim E. Cutler
  • Publication number: 20080003616
    Abstract: Element tags based on novel metal-polymer conjugates are provided for elemental analysis of analytes, including ICP-MS. A polymer backbone is functionalized to irreversibly bind metals that are selected prior to use by the user. The polymer is further functionalized to attach a linker which allows for attachment to antibodies or other affinity reagents. The polymer format allows attachment of many copies of a given isotope, which linearly improves sensitivity. The metal-polymer conjugate tags enable multiplexed assay in two formats: bulk assay, where the average biomarker distribution in the sample is diagnostic, and single cell format to distinguish a rare (for example a diseased) cell in a complex sample (for example, blood).
    Type: Application
    Filed: May 28, 2007
    Publication date: January 3, 2008
    Inventors: Mitchell Winnik, Mark Nitz, Vladimir Baranov, Xudong Lou
  • Publication number: 20060058506
    Abstract: The present invention provides methods of making and using immunogenic oligosaccharide compositions comprising native O-linked and S-linked oligosaccharides coupled to a protein carrier, wherein the resultant conjugate elicits a protectively immunogenic response. These compositions may be useful in vaccines against pathogenic Candida species.
    Type: Application
    Filed: April 25, 2003
    Publication date: March 16, 2006
    Inventors: David Bundle, Mark Nitz, Jim Cutler